fda compounding semaglutide news october 2025 A secret shopper study found that the majority of weight-loss clinics and medical spas in two states offered compounded tirzepatide and after shortages were resolved. Over half of the suppliers combined 'They won't be able to

However, novel promising combination therapies are being developed, including those that couple immunomodulators with drugs that stimulate -cell regeneration in order to restore normoglycaemia

Our results help clarify inconsistencies in previous literature

Use is especially high among adults ages 50 to 64 and among individuals with diabetes, heart disease, or obesity

It depends on your goals and diet

Medicare to start covering GLP-1 weight-loss therapies on July 1, 2026 May 2026 The Centers for Medicare & Medicaid Services (CMS) has launched the GLP-1 Bridge Program, a temporary initiative to provide coverage for effective weight-loss medications

Lanzkron S, Domm J, and Sweet K